MyMD
  • Contact MyMD
  • About Us
    • Team
  • Pipeline
    • MYMD-1®
    • Supera-CBD
  • Research
    • Clinical Trials
  • Investors
  • News
    • MyMD News
    • Press Releases
    • Thought leadership
    • Perspectives
  • Subscribe
  • Contact MyMD

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jan 05, 2022 9:15am EST

MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia

Dec 29, 2021 9:15am EST

MyMD Pharmaceuticals Investment Company Oravax Medical Signs Cooperation and Purchase Agreement for Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccine to be Commercialized in Southeast Asia

Dec 01, 2021 10:05am EST

MyMD Pharmaceuticals to Participate in Two Investor Conferences During December 2021

Nov 23, 2021 9:25am EST

MyMD Pharmaceuticals Announces Issuance of U.S. Patent Covering Lead Drug Candidate MYMD-1 in a Method of Extending Lifespan

Nov 18, 2021 9:15am EST

MyMD Pharmaceuticals Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America

Nov 16, 2021 9:25am EST

MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan

Oct 26, 2021 10:30am EDT

MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation

Oct 19, 2021 10:30am EDT

MyMD Pharmaceuticals to Discuss its Novel Therapies for Aging and Related Diseases at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21

Oct 05, 2021 10:00am EDT

MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7

Sep 22, 2021 11:00am EDT

MyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

Connect with MyMD Pharmaceuticals

Subscribe to stay up-to-date on new developments at MyMD.

Contact Us

MyMD

© 2023 MyMD Pharmaceuticals™. All Right Reserved

  • Privacy Policy
  • Terms & Conditions

This site is not intended to provide medical advice or to suggest that any product mentioned is safe or efficacious for any disease or condition.

News & Resources

View a collection of articles, thought leadership content and industry news.

Subscribe to receive MyMD announcements
  • This field is for validation purposes and should be left unchanged.